These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38959155)

  • 1. The effects of acute versus repeated cannabidiol administration on trauma-relevant emotional reactivity: A double-blind, randomized, placebo-controlled trial.
    Gournay LR; Ferretti ML; Nguyen AM; Bilsky S; Shields GS; Mann E; Williams P; Woychesin S; Bonn-Miller M; Leen-Feldner EW
    J Trauma Stress; 2024 Jul; ():. PubMed ID: 38959155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of cannabidiol on worry and anxiety among high trait worriers: a double-blind, randomized placebo controlled trial.
    Gournay LR; Ferretti ML; Bilsky S; Vance E; Nguyen AM; Mann E; Williams P; Leen-Feldner EW
    Psychopharmacology (Berl); 2023 Oct; 240(10):2147-2161. PubMed ID: 37552290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy.
    Perry MS
    Epilepsy Curr; 2019; 19(2):93-95. PubMed ID: 30955420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The acute effects of cannabidiol on emotional processing and anxiety: a neurocognitive imaging study.
    Bloomfield MAP; Yamamori Y; Hindocha C; Jones APM; Yim JLL; Walker HR; Statton B; Wall MB; Lees RH; Howes OD; Curran VH; Roiser JP; Freeman TP
    Psychopharmacology (Berl); 2022 May; 239(5):1539-1549. PubMed ID: 35445839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabidiol (CBD) Products: Use Patterns and Perceptions Within a Sample of Anxious Users.
    Gournay LR; Ferretti ML; Zvorsky I; Fernandez DA; Leen-Feldner EW
    Subst Use Misuse; 2024 Jun; ():1-9. PubMed ID: 38946130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the efficacy, safety, and pharmacokinetics of nanodispersible cannabidiol oral solution (150 mg/mL) versus placebo in mild to moderate anxiety subjects: A double blind multicenter randomized clinical trial.
    Gundugurti PR; Banda N; Yadlapalli SSR; Narala A; Thatikonda R; Kocherlakota C; Kothapalli KS
    Asian J Psychiatr; 2024 Jul; 97():104073. PubMed ID: 38797087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabidiol for moderate-severe insomnia: a randomized controlled pilot trial of 150 mg of nightly dosing.
    Narayan AJ; Downey LA; Rose S; Di Natale L; Hayley AC
    J Clin Sleep Med; 2024 May; 20(5):753-763. PubMed ID: 38174873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD).
    Hardy J; Haywood A; Gogna G; Martin J; Yates P; Greer R; Good P
    Trials; 2020 Jul; 21(1):611. PubMed ID: 32631447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind, randomized, placebo-controlled test of the effects of cannabidiol on fear elicited by a 10% carbon dioxide-enriched air breathing challenge.
    Leen-Feldner EW; Bynion TM; Eglit GML; Bonn-Miller MO; Gournay LR; Feldner MT
    Psychopharmacology (Berl); 2022 Oct; ():. PubMed ID: 36241853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating cannabidiol (CBD) expectancy effects on acute stress and anxiety in healthy adults: a randomized crossover study.
    Spinella TC; Stewart SH; Naugler J; Yakovenko I; Barrett SP
    Psychopharmacology (Berl); 2021 Jul; 238(7):1965-1977. PubMed ID: 33813611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of cannabidiol placebo on responses to an acute stressor: A replication and proof of concept study.
    Zhekova RM; Perry RN; Spinella TC; Dockrill K; Stewart SH; Barrett SP
    J Psychopharmacol; 2024 Jan; 38(1):116-124. PubMed ID: 38214314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Double-Blind, Randomized, Placebo-Controlled Test of the Effects of Cannabidiol on Experiences of Test Anxiety Among College Students.
    Stanley TB; Ferretti ML; Bonn-Miller MO; Irons JG
    Cannabis Cannabinoid Res; 2023 Dec; 8(6):1090-1099. PubMed ID: 35861792
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder.
    Bolsoni LM; Crippa JAS; Hallak JEC; Guimarães FS; Zuardi AW
    Psychopharmacology (Berl); 2022 May; 239(5):1499-1507. PubMed ID: 35029706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, placebo-controlled, 28-day safety and pharmacokinetics evaluation of repeated oral cannabidiol administration in healthy dogs.
    Vaughn DM; Paulionis LJ; Kulpa JE
    Am J Vet Res; 2021 May; 82(5):405-416. PubMed ID: 33904801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial.
    Hurd YL; Spriggs S; Alishayev J; Winkel G; Gurgov K; Kudrich C; Oprescu AM; Salsitz E
    Am J Psychiatry; 2019 Nov; 176(11):911-922. PubMed ID: 31109198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and cognitive improvement following full-spectrum, high-cannabidiol treatment for anxiety: open-label data from a two-stage, phase 2 clinical trial.
    Dahlgren MK; Lambros AM; Smith RT; Sagar KA; El-Abboud C; Gruber SA
    Commun Med (Lond); 2022 Nov; 2(1):139. PubMed ID: 36352103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Cannabidiol (CBD) oil in the treatment of PTSD: Study design and rationale for a placebo-controlled randomized clinical trial.
    Telch MJ; Fischer CM; Zaizar ED; Rubin M; Papini S
    Contemp Clin Trials; 2022 Nov; 122():106933. PubMed ID: 36154908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of acute and sustained cannabidiol dosing for seven days on the haemodynamics in healthy men: A randomised controlled trial.
    Sultan SR; O'Sullivan SE; England TJ
    Br J Clin Pharmacol; 2020 Jun; 86(6):1125-1138. PubMed ID: 32128848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase IIb Randomized, Placebo-Controlled, Dose-Escalating, Double-Blind Study of Cannabidiol Oil for the Relief of Symptoms in Advanced Cancer (MedCan1-CBD).
    Hardy J; Greer R; Huggett G; Kearney A; Gurgenci T; Good P
    J Clin Oncol; 2023 Mar; 41(7):1444-1452. PubMed ID: 36409969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.